Satoh Eiki, Takahashi Ayako
Research Center for Animal Hygiene and Food Safety, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan.
Diabetes Res Clin Pract. 2008 Aug;81(2):e14-7. doi: 10.1016/j.diabres.2008.04.017. Epub 2008 May 27.
The present study was conducted to investigate the effects of the diabetic condition on the Ca(2+) mobilization and glutamate release in cerebral nerve terminals (synaptosomes). Diabetes was induced in male mice by intraperitoneal injection of streptozotocin. Cytosolic free Ca(2+) concentration (Ca(2+)) and glutamate release in synaptosomes were determined using fura-2 and enzyme-linked fluorometric assay, respectively. Diabetes significantly enhanced the ability of the depolarizing agents K(+) and 4-aminopyridine (4-AP) to increase Ca(2+). In addition, diabetes significantly enhanced K(+)- and 4-AP-evoked Ca(2+)-dependent glutamate release. The pretreatment of synaptosomes with a combination of omega-agatoxin IVA (a P-type Ca(2+) channel blocker) and omega-conotoxin GVIA (an N-type Ca(2+) channel blocker) inhibited K(+)- or 4-AP-induced increases in Ca(2+) and Ca(2+)-dependent glutamate release in synaptosomes from the control and diabetic mice to a similar extent, respectively. These results indicate that diabetes enhances a K(+)- or 4-AP-evoked Ca(2+)-dependent glutamate release by increasing Ca(2+) via stimulation of Ca(2+) entry through both P- and N-type Ca(2+) channels.
本研究旨在探讨糖尿病状态对脑神经终末(突触体)中Ca(2+)动员和谷氨酸释放的影响。通过腹腔注射链脲佐菌素诱导雄性小鼠患糖尿病。分别使用fura-2和酶联荧光测定法测定突触体中的胞质游离Ca(2+)浓度(Ca(2+))和谷氨酸释放。糖尿病显著增强了去极化剂K(+)和4-氨基吡啶(4-AP)增加Ca(2+)的能力。此外,糖尿病显著增强了K(+)和4-AP诱发的Ca(2+)依赖性谷氨酸释放。用ω-芋螺毒素IVA(一种P型Ca(2+)通道阻滞剂)和ω-芋螺毒素GVIA(一种N型Ca(2+)通道阻滞剂)联合预处理突触体,分别在相似程度上抑制了对照小鼠和糖尿病小鼠突触体中K(+)或4-AP诱导的Ca(2+)增加以及Ca(2+)依赖性谷氨酸释放。这些结果表明,糖尿病通过刺激Ca(2+)通过P型和N型Ca(2+)通道进入来增加Ca(2+),从而增强K(+)或4-AP诱发的Ca(2+)依赖性谷氨酸释放。